Chambio Co., Ltd.

7 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Sep 2040

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Sep 12 to 19, 2027 · next Sep 12

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Patent	Title	Status	Expires	Confidence
US 11,517,596	Method for alleviating arthritis with postbiotic extract In force Ends no later than Sep 29, 2040 · From the USPTO record	In force	Ends no later than Sep 29, 2040	From the USPTO record
US 11,517,597	Method for improving skin condition with postbiotic extract In force Ends no later than Sep 29, 2040 · From the USPTO record	In force	Ends no later than Sep 29, 2040	From the USPTO record
US 11,541,085	Postbiotic extract and preparation process and use thereof In force Term ends Sep 29, 2040 · From the USPTO record	In force	Term ends Sep 29, 2040	From the USPTO record
US 11,925,668	Postbiotic extract and preparation process and use thereof In force Term ends Sep 29, 2040 · From the USPTO record	In force	Term ends Sep 29, 2040	From the USPTO record
US 11,931,388	Postbiotic extract and preparation process and use thereof In force Term ends Sep 29, 2040 · From the USPTO record	In force	Term ends Sep 29, 2040	From the USPTO record
US 12,090,182	Method for preventing or alleviating particulate matter-induced lung injury In force Term ends Nov 18, 2041 · From the USPTO record	In force	Term ends Nov 18, 2041	From the USPTO record
US 12,778,995	Method of Using a Combination of Postbiotics and Probiotics for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Associated Disorders In force Ends no later than Oct 26, 2044 · Medium confidence	In force	Ends no later than Oct 26, 2044	Medium confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

Every application published under this name has become a patent.